New study tracks stargardt disease to pave way for future treatments
NCT ID NCT06591806
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 80 people aged 8 to 50 with Stargardt disease, a genetic eye condition that causes vision loss. Researchers will monitor how the disease changes over time using eye imaging. The goal is to better understand the disease and prepare for future clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help design better future treatments for Stargardt disease by identifying how the disease progresses.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve participants' vision or health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STARGARDT DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oslo University hospital Ullevål
Oslo, 0450, Norway
-
Retina Foundation of the Southwest
Dallas, Texas, 75231, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can stem cells restore vision in stargardt disease? a First-in-Human trial aims to find out
- Could stem cells restore sight in damaged eyes?
- New eye camera could unlock secrets of inherited blindness
- New cell therapy aims to slow vision loss in retinal disease
- Thousands join fight against blindness by sharing their stories
- Why do some blind people see things that Aren't there? new study aims to find out